InsiderTrades

Form 4 for IOSP INNOSPEC INC.

Accepted 2023-03-09 00:00:00 ET · period of report 2023-02-24 · accession 0001209191-23-017640 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2023-03-09 2023-03-02+ IOSP Williams Patrick Pres, CEO S - Sale+OE $109.05 -22.9K 139.2K -14% -$2.50M
D 2023-03-09 2023-03-03 IOSP Williams Patrick Pres, CEO M - OptEx $0.00 +3,967 161.3K +3% $0
DM 2023-03-09 2023-02-24+ IOSP Williams Patrick Pres, CEO M - OptEx $0.00 0 0 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-03 S D 2,610 $108.85 145,086 D — — (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $108.44 to $109.42, inclusive.
2 Common Common Stock 2023-03-03 M A 3,967 $0.00 161,337 D — —
3 Common Common Stock 2023-03-02 S D 3,853 $108.42 157,484 D — — (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $107.68 to $108.67, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), (10) and (11) to this Form 4.
4 Common Common Stock 2023-03-02 S D 6,293 $109.05 151,191 D — — (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $108.68 to $109.51, inclusive.
5 Common Common Stock 2023-03-02 S D 1,294 $109.83 149,897 D — — (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $109.69 to $109.88, inclusive.
6 Common Common Stock 2023-03-03 S D 2,201 $108.11 147,696 D — — (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $107.44 to $108.435, inclusive.
7 Common Common Stock 2023-03-03 S D 717 $110.92 138,458 D — — (F11) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $110.49 to $111.35, inclusive.
8 Common Common Stock 2023-03-03 S D 1,320 $109.78 143,766 D — — (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $109.49 to $110.44, inclusive.
9 Common Common Stock 2023-03-03 S D 1,341 $110.95 142,425 D — — (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $110.49 to $111.35, inclusive.
10 Common Common Stock 2023-03-03 S D 1,159 $108.14 141,266 D — — (F8) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $107.44 to $108.43, inclusive.
11 Common Common Stock 2023-03-03 S D 1,377 $108.92 139,889 D — — (F9) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $108.44 to $109.41, inclusive.
12 Common Common Stock 2023-03-03 S D 714 $109.74 139,175 D — — (F10) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $109.47 to $110.25, inclusive.
13 Derivative Employee Stock Option 2023-03-03 M D 3,967 $0.00 0 D $95.70 · 2023-02-24 to 2030-02-24 3,967 Common Stock
14 Derivative Employee Stock Option 2023-02-24 M A 3,967 $0.00 0 D $95.70 · 2023-02-24 to 2030-02-24 3,967 Common Stock (F12) Represents the total number of shares underlying an Option that vested upon certification of the achievement of the performance goals for the Option that was originally granted to the Reporting Person on February 24, 2020.